Page 1 | Search Results | Blood | American Society of Hematology

1-17 of 17

Sort by

Sort Order Select

Journal Articles

High Success Rates Utilizing Local Standard of Care Cytogenetic Testing for Risk Stratified Frontline Therapy for Newly Diagnosed Multiple Myeloma: Experience from the Ukmra RADAR Study

Blood (2023) 142 (Supplement 1): 6715.

https://doi.org/10.1182/blood-2023-188697

Published: 2023

Journal Articles

Karyosequencing: Integrating Genome-Wide and Targeted Sequencing for Comprehensive Diagnosis of Lymphoproliferative Disorders

James Peter Stewart, Louise Harewood, Shambhavi Srivastava, Jana Gazdova, Manisha Maurya, Sirintra Nakjang, Elizabeth Hodges, Laura Chiecchio, Nicholas C.P. Cross, Matthew W Jenner, Mark Catherwood, Sarra Ryan, Anthony V. Moorman, Nikos Darzentas, David Gonzalez

Blood (2021) 138 (Supplement 1): 272.

https://doi.org/10.1182/blood-2021-152258

Published: 2021

Journal Articles

Subclonal TP53 copy number is associated with prognosis in multiple myeloma

Blood (2018) 132 (23): 2465–2469.

https://doi.org/10.1182/blood-2018-06-857250

Published: 2018

Includes: Supplemental data

Journal Articles

Characterisation of Long-Term Responders to First-Line Myeloma Therapy - Results from the UK Myeloma IX and XI Trials

Blood (2018) 132 (Supplement 1): 2000.

https://doi.org/10.1182/blood-2018-99-110149

Published: 2018

Journal Articles

De novo Richter transformation

Laura Chiecchio, Jonathan Oliver Cullis

Blood (2017) 129 (17): 2455.

https://doi.org/10.1182/blood-2017-02-766782

Published: 2017

Journal Articles

Surface IgM expression and function are associated with clinical behavior, genetic abnormalities, and DNA methylation in CLL

Annalisa D’Avola, Samantha Drennan, Ian Tracy, Isla Henderson, Laura Chiecchio, Marta Larrayoz, Matthew Rose-Zerilli, Jonathan Strefford, Christoph Plass, Peter W. Johnson, Andrew J. Steele, Graham Packham, Freda K. Stevenson, Christopher C. Oakes, Francesco Forconi

Blood (2016) 128 (6): 816–826.

https://doi.org/10.1182/blood-2016-03-707786

Published: 2016

Includes: Supplemental data

Journal Articles

Surface IgM Levels Independently Influence Clinical Behavior and Associate with Altered Phenotype and Genetics in Chronic Lymphocytic Leukemia

Samantha J Drennan, PhD, Annalisa D'Avola, MSc, Ian Tracy, Isla Henderson, Marta Larrayoz, PhD, Carina Mundy, Andrew S. Duncombe, MD, Andrew J. Davies, MD PhD, Davide Rossi, MD PhD, Fiona M Ross, DPhil, Laura Chiecchio, PhD, Kathleen N. Potter, PhD, Jonathan Strefford, PhD, Andrew J Steele, PhD, Peter W Johnson, MD, Graham Packham, PhD, Freda K Stevenson, DPhil, Francesco Forconi, MD DM, PhD FRCPath

Blood (2014) 124 (21): 830.

https://doi.org/10.1182/blood.V124.21.830.830

Published: 2014

Journal Articles

Aberrant global methylation patterns affect the molecular pathogenesis and prognosis of multiple myeloma

Brian A. Walker, Christopher P. Wardell, Laura Chiecchio, Emma M. Smith, Kevin D. Boyd, Antonino Neri, Faith E. Davies, Fiona M. Ross, Gareth J. Morgan

Blood (2011) 117 (2): 553–562.

https://doi.org/10.1182/blood-2010-04-279539

Published: 2011

Includes: Supplemental data

Journal Articles

Defining High Risk Myeloma Using Co-Segregating FISH Variables; Results of MRC Myeloma IX

Kevin D Boyd, MBBS, Fiona M. Ross, PhD, William J Tapper, PhD, Laura Chiecchio, PhD, GianPaolo Dagrada, Rebecca Protheroe, David Stockley, Zoe Konn, Walter M Gregory, PhD, Brian A Walker, PhD, Christopher P Wardell, PhD, Faith E Davies, MD, Gareth J Morgan, MD, PhD

Blood (2010) 116 (21): 1907.

https://doi.org/10.1182/blood.V116.21.1907.1907

Published: 2010

Journal Articles

Deletion 13, Detected by Metaphase Analysis, Is Not a Significant Prognostic Indicator In Myeloma

Fiona M. Ross, DPhil, Laura Chiecchio, PhD, GianPaolo Dagrada, BSc, William J Tapper, PhD, Zoe J Konn, BSc, Kan Luk Cheung, BSc, Rebecca KM Protheroe, BSc, David M Stockley, BSc, Susan E Bell, DPhil, Walter M Gregory, PhD, Alexander J Szubert, MSc, Gordon Cook, MD, Roger G. Owen, MD, Mark T. Drayson, MD, Graham Jackson, DM, Faith Davies, MD, PhD, J. Anthony Child, MD, Gareth J Morgan, MD, PhD

Blood (2010) 116 (21): 2980.

https://doi.org/10.1182/blood.V116.21.2980.2980

Published: 2010

Journal Articles

A compendium of myeloma-associated chromosomal copy number abnormalities and their prognostic value

Brian A. Walker, Paola E. Leone, Laura Chiecchio, Nicholas J. Dickens, Matthew W. Jenner, Kevin D. Boyd, David C. Johnson, David Gonzalez, Gian Paolo Dagrada, Rebecca K. M. Protheroe, Zoe J. Konn, David M. Stockley, Walter M. Gregory, Faith E. Davies, Fiona M. Ross, Gareth J. Morgan

Blood (2010) 116 (15): e56–e65.

https://doi.org/10.1182/blood-2010-04-279596

Published: 2010

Includes: Supplemental data

Journal Articles

Gain of 1q21 Does Not Predict for Immediate Progression in MGUS.

Laura Chiecchio, Gian Paolo Dagrada, Elizabet Dachs Cabanas, Rebecca K.M. Protheroe, David M. Stockley, Zoe J. Konn, Nicholas C.P. Cross, Christine J. Harrison, Fiona M. Ross

Blood (2009) 114 (22): 123.

https://doi.org/10.1182/blood.V114.22.123.123

Published: 2009

Journal Articles

High Resolution Genomic Profiling Using Single Nucleotide Polymorphism Microarrays Identifies Multiple Novel Genomic Minimally Deleted Regions in Multiple Myeloma

Brian A WalKer, PhD, Paola E Leone, PhD, Nicholas J Dickens, DPhil, Matthew W Jenner, MD, Laura Chiecchio, GianPaolo Dagrada, Fiona M Ross, DPhil, Faith E Davies, MD, Gareth J Morgan, MD, PhD

Blood (2008) 112 (11): 625.

https://doi.org/10.1182/blood.V112.11.625.625

Published: 2008

Journal Articles

Multiple Myeloma with IGH-Involving del(14q): Report of 34 Cases.

Iwona Wlodarska, PhD, Fiona M. Ross, PhD, Lisa J. Russell, PhD, Helena Pospisilova, Laura Chiecchio, Marie-Astrid Van Caillie, MD, GianPaolo Dagrada, Christiane De Wolf-Peeters, MD, PhD, Christine J. Harrison, PhD, Pascale De Paepe, MD, PhD, Peter Vandenberghe, MD, PhD, Lucienne Michaux, MD, PhD

Blood (2007) 110 (11): 991.

https://doi.org/10.1182/blood.V110.11.991.991

Published: 2007

Journal Articles

Gene mapping and expression analysis of 16q loss of heterozygosity identifies WWOX and CYLD as being important in determining clinical outcome in multiple myeloma

Matthew W. Jenner, Paola E. Leone, Brian A. Walker, Fiona M. Ross, David C. Johnson, David Gonzalez, Laura Chiecchio, Elisabet Dachs Cabanas, Gian Paolo Dagrada, Mathew Nightingale, Rebecca K. M. Protheroe, David Stockley, Monica Else, Nicholas J. Dickens, Nicholas C. P. Cross, Faith E. Davies, Gareth J. Morgan

Blood (2007) 110 (9): 3291–3300.

https://doi.org/10.1182/blood-2007-02-075069

Published: 2007

Includes: Supplemental data

Journal Articles

Abnormalities of 16q in Multiple Myeloma Are Associated with Poor Prognosis: 500K Gene Mapping and Expression Correlations Identify Two Potential Tumor Suppressor Genes, WWOX and CYLD .

Matthew W. Jenner, MD, Paola E. Leone, PhD, Brian A. Walker, PhD, David C. Johnson, BSc, Laura Chiecchio, MSc, Elisabet Dachs Cabanas, BSc, Gian Paolo Dagrada, MSc, Mathew Nightingale, Rebecca K.M. Protheroe, BSc, David Stockley, BSc, Monica Else, MSc, Fiona M. Ross, PhD, Nicholas C.P. Cross, PhD, Faith E. Davies, MD, Gareth J. Morgan, MD, PhD

Blood (2006) 108 (11): 110.

https://doi.org/10.1182/blood.V108.11.110.110

Published: 2006

Journal Articles

Critical Importance of Conventional Cytogenetics in Detecting Prognostically Significant Chromosome 13 Deletions in Myeloma.

Laura Chiecchio, MBS, Rebecca K.M. Protheroe, BSc, Tim Parker, BSc, Christina Rudduck, PhD, Kan Luk Cheung, BSc, Gianpaolo Dagrada, MBS, Ashutosh Wechalekar, MD, Mathew Nightingale, BSc, Christine J. Harrison, PhD, Nicholas C.P. Cross, PhD, Fiona M. Ross, DPhil

Blood (2005) 106 (11): 1544.

https://doi.org/10.1182/blood.V106.11.1544.1544

Published: 2005

NARROW

High Success Rates Utilizing Local Standard of Care Cytogenetic Testing for Risk Stratified Frontline Therapy for Newly Diagnosed Multiple Myeloma: Experience from the Ukmra RADAR Study

Karyosequencing: Integrating Genome-Wide and Targeted Sequencing for Comprehensive Diagnosis of Lymphoproliferative Disorders

Subclonal TP53 copy number is associated with prognosis in multiple myeloma

Characterisation of Long-Term Responders to First-Line Myeloma Therapy - Results from the UK Myeloma IX and XI Trials

De novo Richter transformation

Surface IgM expression and function are associated with clinical behavior, genetic abnormalities, and DNA methylation in CLL

Surface IgM Levels Independently Influence Clinical Behavior and Associate with Altered Phenotype and Genetics in Chronic Lymphocytic Leukemia

Aberrant global methylation patterns affect the molecular pathogenesis and prognosis of multiple myeloma

Defining High Risk Myeloma Using Co-Segregating FISH Variables; Results of MRC Myeloma IX

Deletion 13, Detected by Metaphase Analysis, Is Not a Significant Prognostic Indicator In Myeloma

A compendium of myeloma-associated chromosomal copy number abnormalities and their prognostic value

Gain of 1q21 Does Not Predict for Immediate Progression in MGUS.

High Resolution Genomic Profiling Using Single Nucleotide Polymorphism Microarrays Identifies Multiple Novel Genomic Minimally Deleted Regions in Multiple Myeloma

Multiple Myeloma with IGH-Involving del(14q): Report of 34 Cases.

Gene mapping and expression analysis of 16q loss of heterozygosity identifies WWOX and CYLD as being important in determining clinical outcome in multiple myeloma

Abnormalities of 16q in Multiple Myeloma Are Associated with Poor Prognosis: 500K Gene Mapping and Expression Correlations Identify Two Potential Tumor Suppressor Genes, WWOX and CYLD .

Critical Importance of Conventional Cytogenetics in Detecting Prognostically Significant Chromosome 13 Deletions in Myeloma.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only